Sort
64,565 grants matching “drug discovery”
MIGRAINE--PATHOPHYSIOLOGY AND TREATMENT MECHANISMS
$1,144,788Massachusetts General Hospital · P01 · FY2000 · NS
Discovering accumulation guidelines and applying them to develop new antibiotics for Gram-negative pathogens
$1,144,714Paul Hergenrother · University Of Illinois At Urbana-Champaign · R01 · FY2025 · AI
Harnessing Molecular Networks of Resilience for Therapeutic Discoveries in AD
$1,144,570Nilufer Ertekin-Taner · Mayo Clinic Jacksonville · R01 · FY2018 · AG
A functional evolutionary genetic approach to combat viral infection
$1,144,500John W. Schoggins · Ut Southwestern Medical Center · DP1 · FY2020 · AI
Personalized Cystic Fibrosis Therapy and Research Center
$1,144,093Anjaparavanda P Naren · Cincinnati Childrens Hosp Med Ctr · P30 · FY2021 · DK
Molecular Pathogenesis of Neoplasia
$1,143,869Russell Lonser · National Institute Of Neurological Disorders And Stroke · ZIA · FY2009 · NS
Molecular Correlates Of Human Ca2+ Channel Regulation
$1,143,539Nikolai Soldatov · National Institute On Aging · Z01 · FY2008 · AG
Human Microphysiology Systems Disease Model of Type 2 Diabetes Starting with Liver and pancreatic Islets
$1,143,103D. Lansing Taylor · University Of Pittsburgh At Pittsburgh · UG3 · FY2019 · DK
Center for Genomics and Society
$1,142,549Gail E Henderson · Univ Of North Carolina Chapel Hill · P50 · FY2011 · HG
First-in-Class Macrocyclic Peptide Therapeutic For Rheumatoid Arthritis
$1,142,534Dat Quang Tran · Oryn Therapeutics, Llc · R44 · FY2015 · AR
Open Drug Discovery Center for Alzheimer's Disease
$1,142,384Allan I Levey · Emory University · U54 · FY2023 · AG
TB Surrogate Markers for Assessing Reponse to Treatment (TB SMART Study)
$1,142,366Payam Nahid · University Of California, San Francisco · R01 · FY2017 · AI
Identification of novel MDR antimicrobials from insect-Streptomyces symbioses
$1,142,106Cameron Robert Currie · University Of Wisconsin-Madison · U19 · FY2020 · AI
Novel Therapeutic Strategies Targeting Re-emerging Alphaviruses
$1,142,044Daniel N Streblow · University Of Alabama At Birmingham · U19 · FY2017 · AI
Metal-Catalyzed Methods for Organic Synthesis
$1,141,967Stephen L Buchwald · Massachusetts Institute Of Technology · R35 · FY2022 · GM
Metal-Catalyzed Methods for Organic Synthesis
$1,141,967Stephen L Buchwald · Massachusetts Institute Of Technology · R35 · FY2025 · GM
Metal-Catalyzed Methods for Organic Synthesis
$1,141,967Stephen L Buchwald · Massachusetts Institute Of Technology · R35 · FY2023 · GM
Metal-Catalyzed Methods for Organic Synthesis
$1,141,967Stephen L Buchwald · Massachusetts Institute Of Technology · R35 · FY2024 · GM
Effect of Tumors on the Skeleton
$1,141,868Florent Elefteriou · Vanderbilt University · P01 · FY2009 · CA
Preclinical Alzheimers Disease Drug Development of Novel MAPK Inhibitors
$1,141,669D. Martin Watterson · Northwestern University At Chicago · U01 · FY2014 · AG
DCTD Human Toxicology and Pharmacology
$1,141,659David Heimbrook · Leidos Biomedical Research, Inc. · N01 · FY2015 · CA
Role of a psychiatric disease risk factor in synaptic function and gene transcription regulation
$1,141,539Hongjun Song · University Of Pennsylvania · U19 · FY2020 · MH
Discovering antimicrobials acting against MDR pathogens
$1,141,522Kim Lewis · Northeastern University · R01 · FY2023 · AI
Small-molecule inhibitors of flavivirus entry
$1,141,241Priscilla Li-Ning Yang · Harvard Medical School · U19 · FY2014 · AI
Novel Small-Molecule Therapies for CF
$1,140,903Alan S Verkman · University Of California, San Francisco · P30 · FY2011 · DK